US health policy and prescription drug coverage of FDA-approved medications for the treatment of obesity

被引：0
|
作者：
G Gomez
F C Stanford
机构：
[1] Brigham and Women’s Hospital,Department of Surgery
[2] Harvard Medical School,Urology
[3] Weight Center,Department of Medicine
[4] Gastrointestinal Unit,Department of Pediatrics
[5] Massachusetts General Hospital,Endocrinology
[6] Massachusetts General Hospital,undefined
[7] Harvard Medical School,undefined
来源：
International Journal of Obesity | 2018年 / 42卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：495 / 500
页数：5
相关论文
共 50 条
  • [1] US health policy and prescription drug coverage of FDA-approved medications for the treatment of obesity
    Gomez, G.
    Stanford, F. C.
    INTERNATIONAL JOURNAL OF OBESITY, 2018, 42 (03) : 495 - 500
  • [2] Reporting of Drug Benefit in FDA-Approved Prescription Drug Labeling
    Bansri Desai
    Kyungwan Hong
    John H. Powers
    Peter Doshi
    Journal of General Internal Medicine, 2020, 35 : 377 - 379
  • [3] Reporting of Drug Benefit in FDA-Approved Prescription Drug Labeling
    Desai, Bansri
    Hong, Kyungwan
    Powers, John H.
    Doshi, Peter
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2020, 35 (01) : 377 - 379
  • [4] 2023 FDA-approved psychotropic medications
    Naguy, Ahmed
    Alayadhi, Nadyah
    Pridmore, Saxby
    Alhazeem, Hessa
    Alamiri, Bibi
    ASIAN JOURNAL OF PSYCHIATRY, 2023, 87
  • [5] Newly FDA-approved psychotropic medications
    Naguy, Ahmed
    Pridmore, Saxby
    Alamiri, Bibi
    ASIAN JOURNAL OF PSYCHIATRY, 2022, 77
  • [6] Primary Care Physicians' Use of FDA-Approved Prescription Drug Labels
    Sullivan, Helen W.
    O'Donoghue, Amie C.
    Aikin, Kathryn J.
    JOURNAL OF THE AMERICAN BOARD OF FAMILY MEDICINE, 2014, 27 (05) : 694 - 698
  • [7] Safety assessment of FDA-approved (orlistat and lorcaserin) anti-obesity medications
    Halpern, Bruno
    Halpern, Alfredo
    EXPERT OPINION ON DRUG SAFETY, 2015, 14 (02) : 305 - 315
  • [8] FDA-approved medications that impair human spermatogenesis
    Ding, Jiayi
    Shang, Xuejun
    Zhang, Zhanhu
    Jing, Hua
    Shao, Jun
    Fei, Qianqian
    Rayburn, Elizabeth R.
    Li, Haibo
    ONCOTARGET, 2017, 8 (06) : 10714 - 10725
  • [9] FDA-Approved Medications to Treat Tardive Dyskinesia
    McEvoy, Joseph P.
    JOURNAL OF CLINICAL PSYCHIATRY, 2020, 81 (01)
  • [10] 2024 FDA-approved psychotropic medications: A conspectus
    Naguy, Ahmed
    Alayadhi, Nadyah
    Al-Tajali, Ali
    Ozidu, Victoria
    ASIAN JOURNAL OF PSYCHIATRY, 2024, 102
12345